Your browser doesn't support javascript.
loading
A 52-week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N-ISM study.
Kitazawa, Masaru; Katagiri, Takashi; Suzuki, Hiromi; Matsunaga, Satoshi; H Yamada, Mayuko; Ikarashi, Tomoo; Yamamoto, Masahiko; Furukawa, Kazuo; Iwanaga, Midori; Hatta, Mariko; Fujihara, Kazuya; Yamada, Takaho; Tanaka, Shiro; Sone, Hirohito.
Afiliação
  • Kitazawa M; Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.
  • Katagiri T; Kashiwazaki General Hospital and Medical Center, Kashiwazaki, Japan.
  • Suzuki H; Niigata Prefectural Shibata Hospital, Shibata, Japan.
  • Matsunaga S; Niigata Prefectural Chuo Hospital, Joetsu, Japan.
  • H Yamada M; Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.
  • Ikarashi T; Niigata Medical Center, Niigata, Japan.
  • Yamamoto M; Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.
  • Furukawa K; Nagaoka Red Cross Hospital, Nagaoka, Japan.
  • Iwanaga M; Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.
  • Hatta M; Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.
  • Fujihara K; Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.
  • Yamada T; Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.
  • Tanaka S; Department of Clinical Biostatistics/Clinical Biostatistics Course, Graduate School of Medicine Kyoto University, Kyoto, Japan.
  • Sone H; Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.
Diabetes Obes Metab ; 23(3): 811-821, 2021 03.
Article em En | MEDLINE | ID: mdl-33416200

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Metformina Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Metformina Idioma: En Ano de publicação: 2021 Tipo de documento: Article